Screener
Aura Biosciences, Inc. AURA Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Aura Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216808
FAQ
- What is Aura Biosciences, Inc.'s debt-to-equity?
- Aura Biosciences, Inc. (AURA) reported debt-to-equity of 0.2× in Q1 2026.
- How has Aura Biosciences, Inc.'s debt-to-equity changed year-over-year?
- Aura Biosciences, Inc.'s debt-to-equity increased by 9.9% year-over-year, from 0.1× to 0.2×.
- What is the long-term trend for Aura Biosciences, Inc.'s debt-to-equity?
- Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s debt-to-equity has grown at a 111.0% compound annual growth rate (CAGR), from 0× to 0.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Aura Biosciences, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude